How do I obtain a urine drug screen for mitragynine (the principal alkaloid in kratom)?

Mitragynine Urine Drug Screen

To obtain a urine drug screen for mitragynine (kratom), you must specifically request specialized testing through liquid chromatography-mass spectrometry (LC-MS/MS) or ELISA-based kratom panels, as mitragynine is NOT detected by standard immunoassay drug screens.

Key Testing Considerations

Standard Drug Screens Do Not Detect Kratom

Standard immunoassay panels used in point-of-care testing cannot identify mitragynine or other kratom alkaloids 1. These conventional screens are designed for naturally occurring opioids (codeine, morphine) and common drugs of abuse, but kratom alkaloids require specific assays 1.

Specialized Testing Methods Required

For mitragynine detection, you need:

• LC-MS/MS (Liquid Chromatography-Mass Spectrometry): The gold standard confirmatory method that can identify and quantify mitragynine, 7-hydroxymitragynine, and related alkaloids 2, 3

  • Detection limits: 0.5-1 ng/mL in urine 2
  • Can detect mitragynine for approximately 24-72 hours post-ingestion 3

• ELISA-based kratom panels: Rapid screening immunoassays specifically developed for mitragynine detection 4, 5

  • Detection limit: 15 ng/mL 5
  • Cross-reacts with kratom metabolites and related alkaloids 5
  • Requires confirmation with LC-MS/MS for positive results

Ordering the Test

When ordering, specify:

1. "Kratom alkaloid screen" or "mitragynine urine test" - do not assume it's included in comprehensive drug panels
2. Request detection of multiple alkaloids: mitragynine, 7-hydroxymitragynine, speciociliatine, speciogynine, and paynantheine 2
3. Confirm your laboratory offers kratom-specific testing, as not all facilities have this capability 6

Clinical Context

Important caveats:

• Timing matters: Collect urine as soon as possible if kratom use is suspected, as some metabolites clear rapidly 6
• Metabolites dominate: 7-hydroxymitragynine and other metabolites may be present in higher concentrations than parent mitragynine 3, 7
• Detection window: Mitragynine and metabolites are typically detectable for 24-72 hours after use 3

Interpretation Pitfalls

• The presence of multiple kratom alkaloids (mitragynine, speciociliatine, speciogynine, paynantheine) indicates consumption of kratom plant material rather than isolated synthetic compounds 8
• Some commercial products labeled as "kratom" contain synthetically concentrated 7-hydroxymitragynine and may not represent traditional kratom leaf 9
• Consult with a clinical pharmacist, certified laboratory professional, or toxicologist for unexpected or complex results 1

Practical Approach

For suspected kratom use:

1. Contact your reference laboratory to verify kratom testing availability
2. Order "kratom alkaloid panel by LC-MS/MS" or "mitragynine screen"
3. Collect urine specimen promptly (first-morning specimen preferred for adequate concentration 10)
4. Document clinical suspicion and timing of suspected use
5. Request confirmatory LC-MS/MS testing if using ELISA screening method

The bottom line: Mitragynine requires specialized testing that must be explicitly requested—it will not appear on routine drug screens, and many laboratories may need to send samples to reference facilities with kratom-specific capabilities.